WO1991012273A3 - Methods of producing hybrid g protein-coupled receptors - Google Patents

Methods of producing hybrid g protein-coupled receptors Download PDF

Info

Publication number
WO1991012273A3
WO1991012273A3 PCT/US1991/000909 US9100909W WO9112273A3 WO 1991012273 A3 WO1991012273 A3 WO 1991012273A3 US 9100909 W US9100909 W US 9100909W WO 9112273 A3 WO9112273 A3 WO 9112273A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein
domain
coupled
methods
coupled receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1991/000909
Other languages
French (fr)
Other versions
WO1991012273A2 (en
Inventor
Andrzej Z Sledziewski
Paul O Sheppard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Priority to JP50556091A priority Critical patent/JP3333506B2/en
Priority to EP91904758A priority patent/EP0594594B1/en
Priority to CA002074837A priority patent/CA2074837C/en
Priority to DE69125953T priority patent/DE69125953T2/en
Publication of WO1991012273A2 publication Critical patent/WO1991012273A2/en
Publication of WO1991012273A3 publication Critical patent/WO1991012273A3/en
Anticipated expiration legal-status Critical
Priority to GR970401545T priority patent/GR3023898T3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Methods are disclosed for producing hybrid G protein-coupled receptors. DNA sequences encoding hybrid G protein-coupled receptors are provided, wherein the receptors comprise mammalian G protein-coupled receptors having at least one domain other than the ligand-binding domain replaced with a corresponding domain of a yeast G protein-coupled receptor. DNA constructs comprising the following operatively linked elements: a transcriptional promoter, a DNA sequence encoding a hybrid G protein-coupled receptor, wherein the receptor comprises a mammalian G protein-coupled receptor having at least one domain other than the ligand-binding domain replaced with a corresponding domain of a yeast G protein-coupled receptor, and a transcriptional terminator. Host cells transformed with the DNA constructs and methods utilizing the transformed cells are also provided.
PCT/US1991/000909 1990-02-08 1991-02-08 Methods of producing hybrid g protein-coupled receptors Ceased WO1991012273A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP50556091A JP3333506B2 (en) 1990-02-08 1991-02-08 Method for producing hybrid G protein-coupled receptor
EP91904758A EP0594594B1 (en) 1990-02-08 1991-02-08 Methods of producing hybrid g protein-coupled receptors
CA002074837A CA2074837C (en) 1990-02-08 1991-02-08 Methods of producing hybrid g protein-coupled receptors
DE69125953T DE69125953T2 (en) 1990-02-08 1991-02-08 MANUFACTURING METHOD FOR HYBRID, G-PROTEIN COUPLED RECEPTORS
GR970401545T GR3023898T3 (en) 1990-02-08 1997-06-26 Methods of producing hybrid g protein-coupled receptors

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/478,100 US5284746A (en) 1990-02-08 1990-02-08 Methods of producing hybrid G protein-coupled receptors
US478,100 1990-02-08

Publications (2)

Publication Number Publication Date
WO1991012273A2 WO1991012273A2 (en) 1991-08-22
WO1991012273A3 true WO1991012273A3 (en) 1991-10-03

Family

ID=23898515

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1991/000909 Ceased WO1991012273A2 (en) 1990-02-08 1991-02-08 Methods of producing hybrid g protein-coupled receptors

Country Status (14)

Country Link
US (2) US5284746A (en)
EP (1) EP0594594B1 (en)
JP (1) JP3333506B2 (en)
AT (1) ATE152479T1 (en)
AU (1) AU7333691A (en)
CA (1) CA2074837C (en)
CS (1) CS31391A2 (en)
DE (1) DE69125953T2 (en)
DK (1) DK0594594T3 (en)
ES (1) ES2100947T3 (en)
GR (1) GR3023898T3 (en)
IE (1) IE63987B1 (en)
PT (1) PT96714B (en)
WO (1) WO1991012273A2 (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401629A (en) 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
JP3348406B2 (en) 1990-09-13 2002-11-20 デューク ユニバーシティー Expression of G protein-coupled receptor in yeast
US5264565A (en) * 1991-01-22 1993-11-23 Affymax Technologies, N.V. Nucleic acid encoding the D2 /Ml chimeric receptor
CA2120518C (en) * 1991-10-01 1998-10-13 Monika Konig A method of identifying ligands and antagonists of ligands
DE4138621A1 (en) * 1991-11-25 1993-06-17 Boehringer Ingelheim Int METHOD FOR SCREENING SUBSTANCES WITH MODULATING EFFECT ON A RECEPTACLE-RELATED CELLULAR SIGNAL TRANSMISSION PATH
US6100042A (en) * 1993-03-31 2000-08-08 Cadus Pharmaceutical Corporation Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
US7235648B1 (en) 1993-03-31 2007-06-26 Cadus Technologies, Inc. Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
US6864060B1 (en) 1993-03-31 2005-03-08 Cadus Technologies, Inc. Yeast cells expressing modified G proteins and methods of use therefor
US6255059B1 (en) * 1993-03-31 2001-07-03 Cadus Pharmaceutical Corporation Methods for identifying G protein coupled receptor effectors
ATE207118T1 (en) * 1993-03-31 2001-11-15 Cadus Pharmaceutical Corp YEAST CELLS DESIGNED TO PRODUCE PROTEIN SURROGATES OF THE PHEROMA SYSTEM AND APPLICATIONS THEREOF
US20030054402A1 (en) * 1993-03-31 2003-03-20 Cadus Pharmaceutical Corporation Methods and compositions for identifying receptor effectors
US7416881B1 (en) * 1993-03-31 2008-08-26 Cadus Technologies, Inc. Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
US5691188A (en) * 1994-02-14 1997-11-25 American Cyanamid Company Transformed yeast cells expressing heterologous G-protein coupled receptor
US6806061B1 (en) 1995-01-19 2004-10-19 Children's Medical Center Corporation G protein-coupled receptor gene and methods of use therefor
US6537764B1 (en) 1995-01-19 2003-03-25 Children's Medical Center Corporation Method of identifying inhibitors of C—C chemokine receptor 3
US6881545B1 (en) 1995-12-28 2005-04-19 Takeda Chemical Industries, Ltd. Polypeptides, their production and use
AU1208497A (en) 1995-12-28 1997-07-28 Takeda Chemical Industries Ltd. Ligand polypeptides for the g-protein-coupled receptor protein, their production and use
US6528271B1 (en) 1997-06-05 2003-03-04 Duke University Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
US5891646A (en) * 1997-06-05 1999-04-06 Duke University Methods of assaying receptor activity and constructs useful in such methods
US7541151B2 (en) 1997-06-05 2009-06-02 Duke University Single-cell biosensor for the measurement of GPCR ligands in a test sample
US6355473B1 (en) 1998-05-06 2002-03-12 Cadus Pharmaceutical Corp. Yeast cells having mutations in stp22 and uses therefor
US6692696B1 (en) * 1998-06-18 2004-02-17 ARETé ASSOCIATES Biosensor
US6312689B1 (en) 1998-07-23 2001-11-06 Millennium Pharmaceuticals, Inc. Anti-CCR2 antibodies and methods of use therefor
US7081360B2 (en) 1998-07-28 2006-07-25 Cadus Technologies, Inc. Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties
US7273747B2 (en) 1998-08-27 2007-09-25 Cadus Technologies, Inc. Cell having amplified signal transduction pathway responses and uses therefor
US7094593B1 (en) * 1998-09-01 2006-08-22 Basf Aktiengesellschaft Method for improving the function of heterologous G protein-coupled receptors
US6251605B1 (en) 1998-10-27 2001-06-26 Cadus Pharmaceutical Corporation Yeast cells having mutations in Cav1 and uses therefor
AU2030000A (en) 1998-11-25 2000-06-13 Cadus Pharmaceutical Corporation Methods and compositions for identifying receptor effectors
US6504008B1 (en) 1999-02-01 2003-01-07 Cadus Technologies, Inc. Cell based signal generation
WO2000075660A1 (en) * 1999-06-08 2000-12-14 The Regents Of The University Of California Methods and compositions for identifying inhibitors of osteoclastic bone reabsorption
US6555325B1 (en) 1999-06-14 2003-04-29 Cadus Technologies, Inc. System for detection of a functional interaction between a compound and a cellular signal transduction component
US7223533B2 (en) 1999-09-10 2007-05-29 Cadus Technologies, Inc. Cell surface proteins and use thereof as indicators of activation of cellular signal transduction pathways
US7324236B2 (en) * 2000-02-01 2008-01-29 Canon Kabushiki Kaisha Discrepancy correction method and apparatus for correcting difference in levels of image signals obtained by an image sensor having a multiple output channels
CA2420325A1 (en) 2000-08-25 2002-02-28 Basf Plant Science Gmbh Plant polynucleotides encoding novel prenyl proteases
US7163800B2 (en) * 2000-11-03 2007-01-16 Molecular Devices Corporation Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
US20050136431A1 (en) * 2000-11-03 2005-06-23 Oakley Robert H. Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
US7018812B2 (en) * 2000-11-03 2006-03-28 Duke University Modified G-protein coupled receptors
EP1326076A3 (en) * 2001-10-26 2004-01-28 Millenium Pharmaceuticals, Inc. Methods for indentification of ligands or modulators of 2871 receptor, a g-protein coupled receptor
NZ534399A (en) 2002-01-25 2008-08-29 G2 Therapies Ltd Monoclonal antibodies against extracellular loops of C5aR
US20030182669A1 (en) * 2002-03-19 2003-09-25 Rockman Howard A. Phosphoinositide 3-kinase mediated inhibition of GPCRs
US7290215B2 (en) * 2002-06-03 2007-10-30 Microsoft Corporation Dynamic wizard interface system and method
US7049076B2 (en) * 2003-07-09 2006-05-23 Sentigen Biosciences, Inc. Method for assaying protein—protein interaction
JP2007521248A (en) 2003-12-10 2007-08-02 ミレニアム ファーマシューティカルズ， インコーポレイテッド Humanized anti-CCR2 antibody and methods of using the antibody
US7572600B2 (en) * 2004-08-04 2009-08-11 Chemocentryx, Inc. Enzymatic activities in chemokine-mediated inflammation
US20070287160A1 (en) * 2006-04-21 2007-12-13 Chou Judy H Methods for high throughput screening of cell lines
RU2009110154A (en) * 2006-08-22 2010-09-27 Джи2 ИНФЛЕММЕЙШН ПТИ ЛТД (AU) ANTIBODIES AGAINST C5aR WITH IMPROVED PROPERTIES
CN104193824A (en) * 2008-02-20 2014-12-10 G2炎症私人有限公司 Humanized anti-c5ar antibodies
PL2718322T3 (en) 2011-06-06 2019-07-31 Novo Nordisk A/S Therapeutic antibodies
US9809862B2 (en) * 2014-08-11 2017-11-07 Georgia Tech Research Corporation G-protein coupled receptor (GPCR)-based biosensors and uses thereof
EP4051694B1 (en) 2019-10-31 2025-07-02 Universität Bern Aav vector variants for ocular gene delivery

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0244221A1 (en) * 1986-04-30 1987-11-04 Genentech, Inc. Hybrid receptors, nucleic acid encoding them, their preparation, and their use in determination of ligands and their antagonists and agonists
EP0351921A2 (en) * 1988-07-22 1990-01-24 Merck & Co. Inc. Modified beta adrenergic receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745057A (en) * 1984-05-18 1988-05-17 Eli Lilly And Company Method, vectors and transformants for high expression of heterologous polypeptides in yeast
US4931373A (en) * 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
US5037743A (en) * 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0244221A1 (en) * 1986-04-30 1987-11-04 Genentech, Inc. Hybrid receptors, nucleic acid encoding them, their preparation, and their use in determination of ligands and their antagonists and agonists
EP0351921A2 (en) * 1988-07-22 1990-01-24 Merck & Co. Inc. Modified beta adrenergic receptor

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Proc. Natl. Acad. Sci. USA, volume 83, March 1986, Genetics, (US), D.C. Hagen et al.: "Evidence the yeast STE3 gene encodes a receptor for the peptide pheromone a factor: gene sequence and implications for the structure of the presumed receptor", pages 1418-1422 *
Proc. Natl. Acad. Sci. USA, volume 85, June 1988, Cell Biology, (US), L. Marsh et al.: "STE2 protein of Saccharomyces kluyveri is a member of the rhodopsin / B-adrenergic receptor family and is responsible for recognition of the peptide ligand & factor", pages 3855-3859 *
Proc. Natl. Acad. Sci., USA, volume 85 October 1988, Biochemistry, (Washington, DC, US), S. Cotecchia et al.: "Molecular cloning and expression of the cDNA for the hamster x1-adrenergic receptor", pages 7159-7163 *

Also Published As

Publication number Publication date
US5284746A (en) 1994-02-08
PT96714A (en) 1991-10-31
ATE152479T1 (en) 1997-05-15
EP0594594B1 (en) 1997-05-02
IE910430A1 (en) 1991-08-14
JP3333506B2 (en) 2002-10-15
PT96714B (en) 1998-07-31
EP0594594A1 (en) 1994-05-04
IE63987B1 (en) 1995-06-28
CA2074837A1 (en) 1991-08-09
CS31391A2 (en) 1991-11-12
DK0594594T3 (en) 1997-09-29
US5576210A (en) 1996-11-19
WO1991012273A2 (en) 1991-08-22
AU7333691A (en) 1991-09-03
ES2100947T3 (en) 1997-07-01
DE69125953T2 (en) 1997-08-21
CA2074837C (en) 2001-11-27
DE69125953D1 (en) 1997-06-05
GR3023898T3 (en) 1997-09-30
JPH05504258A (en) 1993-07-08

Similar Documents

Publication Publication Date Title
AU7333691A (en) Methods of producing hybrid g protein-coupled receptors
AU1846995A (en) Heterologous g protein coupled receptors expressed in yeast, their fusion with g proteins and use thereof in bioassay
AU7575487A (en) Method for the preparation of proteins with factor VIII activity by microbial host cells; expression, vectors, host cells, antibodies
AU5244598A (en) Browse by prompted keyword phrases with an improved method for obtaining an initial document set
ES2094157T3 (en) GAMMA-RETINOIC ACID RECEIVER.
ATE102250T1 (en) INCREASED YEAST TRANSCRIPTION USING A HYBRID CONSTRUCTION OF THE PROMOTER REGION.
WO2000012705A3 (en) Methods for improving the function of heterologous g protein-coupled receptors
AU4639396A (en) Cytokine designated lerk-7
WO1997017450A3 (en) Compositions and methods for producing heterologous polypeptides in pichia methanolica
EP1029915A3 (en) Expression of G protein coupled receptors in yeast
NZ331176A (en) Receptor protein designated 2F1, DNA encoding 2F1, preparation and use thereof
AU1292700A (en) Immune cells having predefined biological specificity, comprising chimeric t cell receptor
WO1995029236A3 (en) Lymphocyte activation antigens and antibodies thereto
AU6145190A (en) New functional bacillus thuringiensis hybrid genes obtained by in vivo recombination
WO1999021976A3 (en) Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
WO1998024906A3 (en) Isolated mammalian monocyte cell genes; related reagents
CA2209858A1 (en) Il-2r-associated polypeptide and dna molecules coding therefor
WO1995007934A3 (en) Il8 inhibitors
AU7289196A (en) Combination of ltd, receptor antagonists with glucocorticosteroids
AU1825097A (en) Mammalian cx3c chemokine genes
WO1998032858A3 (en) Mammalian chemokines; receptors; reagents; uses
EP0207165A4 (en) Polypeptide secretion-causing vector, microorganisms transformed by said vector, and process for preparing polypeptide using said microorganisms.
Bharati Kuch Lambi Kavitayin
AU1812095A (en) A t cell receptor sequence specifically associated with an immune disease
WO2003099779A3 (en) Hemipteran muscarinic receptor

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BB BG BR CA FI HU JP KP KR LK MC MG MW NO PL RO SD SU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BF BJ CF CG CH CM DE DK ES FR GA GB GR IT LU ML MR NL SE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AU BB BG BR CA FI HU JP KP KR LK MC MG MW NO PL RO SD SU

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE BF BJ CF CG CH CM DE DK ES FR GA GB GR IT LU ML MR NL SE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2074837

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1991904758

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1991904758

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1991904758

Country of ref document: EP